1 year return (CAGR)
-
Caris Life Sciences, Inc. Common Stock Exchange (NASDAQ, USD)
CAI
28.50
+2.45 (+9.40%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
8.05B
Price/Sales
8.14
Ent value
8.00B
Price/Book
13.61
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
76.61
PEG
-
Forward P/E
75.42
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 25.80 |
| Daily high | 28.68 |
| Daily low | 25.80 |
| Daily Volume | 8.65M |
| All-time high | 32.95 |
| 1y analyst estimate | 27.00 |
| Beta | - |
| EPS (TTM) | 0.37 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| CAI | S&P500 | |
| Current price drop from All-time high | -13.51% | -2.63% |
| Highest price drop | -55.84% | -56.47% |
| Date of highest drop | 15 May 2026 | 9 Mar 2009 |
| Avg drop from high | -31.62% | -10.68% |
| Avg time to new high | 49 days | 12 days |
| Max time to new high | 235 days | 1805 days |
News
